inThought Research Promotes Dr. Amanda Weyerbacher to Executive Vice President

inThought Research Elevates Dr. Amanda Weyerbacher to Executive VP

In an exciting development on March 31, 2026, inThought Research Inc., a prominent provider of decision support for the life sciences sector, shared the noteworthy news of Dr. Amanda Weyerbacher's promotion to the position of Executive Vice President of Projects and Operations.

Dr. Weyerbacher, who has been an integral part of the inThought team since joining in 2015, previously held the role of Director of Research. In her new role, she will supervise project execution and ensure operational excellence across the organization. Her tasks will involve working closely with project leaders to guarantee that every client benefits from high-quality decision support that inThought is renowned for.

Ben Weintraub, President of inThought, expressed strong support for the decision, stating, "Dr. Weyerbacher is key to inThought's success with various projects, including opportunity assessments and lifecycle management."

Dr. Weyerbacher comes with significant expertise in oncology, immunology, and respiratory diseases, having led many projects in these areas as a Senior Principal. Before her tenure at inThought, she worked as a Senior Scientist at L'Oréal, demonstrating her diverse background and skill set. She holds a PhD in Pharmacology from Weill Cornell Medical College and completed her undergraduate studies at Skidmore College.

In Dr. Weyerbacher's words, "I look forward to supporting our extraordinary team of analysts as they deliver first-class strategic advice to our clients." Her vision for inThought emphasizes the importance of empowering analysts with the necessary tools and resources to excel in their work.

About inThought

inThought Research is dedicated to empowering leaders in the biopharma industry by providing comprehensive strategic insights. By leveraging a unique blend of financial acumen, scientific knowledge, and advanced AI analytics, inThought navigates the multifaceted landscape of drug development. The company's multidisciplinary approach integrates various aspects such as clinical data and market analytics to inform decision-making.

Through its innovative platform, inThought Labs, the organization merges cutting-edge technology with expert insights, transforming complex data into actionable intelligence. For further details about inThought and its offerings, please visit www.inthought.com.

For media inquiries, please contact:
Doug Foster
Chief Operating Officer
Phone: (508) 414-9819
Email: [email protected]

URL: inThought Research Logo